Global Retirement Partners’s NovoCure NVCR Stock Holding History

Global Retirement Partners’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$14.5K	Buy	1,123 +5	+0.4%	+$64	﹤0.01%	3011
2025 Q3	$14.4K	Hold	1,118	–	–	﹤0.01%	2541
2025 Q2	$19.9K	Buy	+1,118	New	+$19.5K	﹤0.01%	2298
2024 Q4	$33.3K	Buy	1,118 +181	+19%	+$3.83K	﹤0.01%	1817
2024 Q3	$14.6K	Hold	937	–	–	﹤0.01%	2144
2024 Q2	$16.1K	Sell	937 -24	-2%	-$422	﹤0.01%	2099
2024 Q1	$15K	Buy	961 +24	+3%	+$353	﹤0.01%	1933
2023 Q4	$11.8K	Buy	+937	New	+$12.5K	﹤0.01%	2002
2023 Q3	–	Sell	-5	Closed	-$208	–	3316
2023 Q2	$208	Sell	5 -4	-44%	-$248	﹤0.01%	3091
2023 Q1	$593	Buy	9 +4	+80%	+$320	﹤0.01%	2883
2022 Q4	$367	Hold	5	–	–	﹤0.01%	2825
2022 Q3	$0	Hold	5	–	–	﹤0.01%	2884
2022 Q2	$0	Hold	5	–	–	﹤0.01%	2818
2022 Q1	$0	Buy	+5	New	+$368	﹤0.01%	2726
2021 Q4	–	Sell	-21	Closed	-$2K	–	1264
2021 Q3	$2K	Sell	21 -39	-65%	-$5.9K	﹤0.01%	1843
2021 Q2	$13K	Hold	60	–	–	﹤0.01%	1318
2021 Q1	$8K	Sell	60 -5	-8%	-$791	﹤0.01%	1359
2020 Q4	$11K	Buy	65 +5	+8%	+$684	﹤0.01%	1242
2020 Q3	$7K	Hold	60	–	–	﹤0.01%	1250
2020 Q2	$4K	Buy	+60	New	+$3.95K	﹤0.01%	1342

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Global Retirement Partners's NVCR Position: Q4 2025 in Review

Global Retirement Partners increased its NovoCure (NVCR) stake by 0.45% in Q4 2025, buying an estimated $64 and bringing the position to 1,123 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3011.

Global Retirement Partners first reported a position in NVCR in Q2 2020 and has held it in 20 quarters since. The position peaked at $33.3K in Q4 2024. 238 funds tracked by Wall St. Rank hold NVCR as of Q4 2025.

Global Retirement Partners held 1,123 shares of NovoCure worth $14.5K as of Q4 2025.
Global Retirement Partners bought 5 NovoCure shares in Q4 2025, an estimated $64.
NovoCure made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3011 holding.
Global Retirement Partners first reported a position in NovoCure in Q2 2020 and has held it in 20 quarters since.
Global Retirement Partners's NovoCure position peaked at $33.3K in Q4 2024.
238 funds tracked by Wall St. Rank held NovoCure as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.